245 related articles for article (PubMed ID: 29319129)
21. Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer?
Campennì A; Pignata SA; Baldari S
Endocrine; 2015 Nov; 50(2):516-8. PubMed ID: 25471282
[TBL] [Abstract][Full Text] [Related]
22. [Imaging of metastases from thyroid carcinomas using 111In-pentetreotide scintigraphy].
Görges R; Eissner D; Kahaly G; Voges E; Kersjes W; Bockisch A
Nuklearmedizin; 1995 Aug; 34(4):165-9. PubMed ID: 7675648
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer.
Haslinghuis LM; Krenning EP; De Herder WW; Reijs AE; Kwekkeboom DJ
J Endocrinol Invest; 2001 Jun; 24(6):415-22. PubMed ID: 11434665
[TBL] [Abstract][Full Text] [Related]
24. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan.
Kaya M; Cermik TF
Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-EDDA/HYNIC-TOC and (18)F-FDG in thyroid cancer patients with negative (131)I whole-body scans.
Gabriel M; Froehlich F; Decristoforo C; Ensinger C; Donnemiller E; von Guggenberg E; Heute D; Moncayo R
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):330-41. PubMed ID: 14625664
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor scintigraphy in non-medullary thyroid cancer.
Postema PT; De Herder WW; Reubi JC; Oei HY; Kwekkeboom DJ; Bruining HJ; Bonjer J; van Toor H; Hennemann G; Krenning EP
Digestion; 1996; 57 Suppl 1():36-7. PubMed ID: 8813465
[TBL] [Abstract][Full Text] [Related]
27. An Unusual Case of Papillary Thyroid Carcinoma Iodine-131 Avid Metastasis to the Adrenal Gland.
Blažeković I; Jukić T; Granić R; Punda M; Franceschi M
Acta Clin Croat; 2018 Jun; 57(2):372-376. PubMed ID: 30431733
[TBL] [Abstract][Full Text] [Related]
28. Cerebellar metastasis as first metastasis from papillary thyroid carcinoma.
Pazaitou-Panayiotou K; Kaprara A; Chrisoulidou A; Boudina M; Georgiou E; Patakiouta F; Drimonitis A; Vainas I
Endocr J; 2005 Dec; 52(6):653-7. PubMed ID: 16410655
[TBL] [Abstract][Full Text] [Related]
29. Distant, solitary skeletal muscle metastasis in recurrent papillary thyroid carcinoma.
Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Choe JH; Kim JH; Kim JS
Thyroid; 2011 Sep; 21(9):1027-31. PubMed ID: 21834676
[TBL] [Abstract][Full Text] [Related]
30. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.
Decristoforo C; Mather SJ; Cholewinski W; Donnemiller E; Riccabona G; Moncayo R
Eur J Nucl Med; 2000 Sep; 27(9):1318-25. PubMed ID: 11007513
[TBL] [Abstract][Full Text] [Related]
31. The relevance of somatostatin receptors in thyroid neoplasia.
Ahlman H; Tisell LE; Wängberg B; Fjälling M; Forssell-Aronsson E; Kölby L; Nilsson O
Yale J Biol Med; 1997; 70(5-6):523-33. PubMed ID: 9825479
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
33. 99m Tc-Octreotide-Avid Brain Mass In A Patient With Poorly Differentiated Papillary Thyroid Carcinoma, Hope In Despair.
Shakeri S; Jahanpanah P; Divband G; Massoudi T; Aryana K
Nucl Med Rev Cent East Eur; 2020; 23(1):49-50. PubMed ID: 32779178
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
35. 111In-octreotide scintigraphy in metastatic medullary thyroid carcinoma before and after octreotide therapy: in vivo evidence of the possible down-regulation of somatostatin receptors.
Ronga G; Salerno G; Procaccini E; Mauro L; Annovazzi A; Barone R; Mellozzi M; Tamburrano G; Signore A
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):134-6. PubMed ID: 9002772
[TBL] [Abstract][Full Text] [Related]
36. Euthyroid status after total thyroidectomy due to functioning lung metastases from a clear cell variant of papillary thyroid carcinoma.
Lee JI; Chung YJ; Park SJ; Ryu HS; Cho BY
Thyroid; 2012 Oct; 22(10):1084-7. PubMed ID: 22873179
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic capabilities of I-131, TI-201, and Tc-99m-MIBI scintigraphy for metastatic differentiated thyroid carcinoma after total thyroidectomy.
Fujie S; Okumura Y; Sato S; Akaki S; Katsui K; Himei K; Takemoto M; Kanazawa S
Acta Med Okayama; 2005 Jun; 59(3):99-107. PubMed ID: 16049563
[TBL] [Abstract][Full Text] [Related]
38. Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma.
Teunissen JJ; Kwekkeboom DJ; Kooij PP; Bakker WH; Krenning EP
J Nucl Med; 2005 Jan; 46 Suppl 1():107S-14S. PubMed ID: 15653659
[TBL] [Abstract][Full Text] [Related]
39. Solitary cerebellar metastasis from papillary thyroid carcinoma: a case report.
Pacak K; Sweeney DC; Wartofsky L; Mark AS; Punja U; Azzam CJ; Burman KD
Thyroid; 1998 Apr; 8(4):327-35. PubMed ID: 9588498
[TBL] [Abstract][Full Text] [Related]
40. Tumor-to-tumor metastases: papillary thyroid carcinoma into a clear cell renal cell carcinoma.
Song JS; Taylor SM; Trites J; Rigby MH; Bullock MJ; Merrimen J; Rendon R; Hart RD
J Otolaryngol Head Neck Surg; 2017 Mar; 46(1):17. PubMed ID: 28249616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]